PDCN for Treatment of Cervical Vertigo
Cervical Vertigo
About this trial
This is an interventional treatment trial for Cervical Vertigo focused on measuring cervical vertigo, percutaneous disc decompression with coblation nucleoplasty, manual therapy, clinical efficacy, randomized controlled trial
Eligibility Criteria
Inclusion Criteria:
- Diagnosis of cervical vertigo upon characteristic symptoms of dizziness associated with neck stiffness and/or neck pain, which is related to movement or position of cervical spine;
- Subjects with obvious disc degeneration verified to exist at MRI;
- All the patients had recurring symptom of dizziness over three months and conservative treatment applied for at least three weeks and failed;
- Male or female aged between 18 and 80;
- Subjects' consent to participate and had signed the informed consent.
Exclusion Criteria:
- Other causes of vertigo, including those arising from disturbances of the ear, nose, and throat (ENT); benign positional paroxysmal vertigo (BPPV); central nervous system (CNS); and cardiovascular system;
- Predominant radiculopathy cervical, cervical myelopathy or cervical stenosis;
- Inflammatory arthritis, neoplastic diseases, infection, trauma;
- History of previous cervical surgeries or cervical spine surgery during the follow-up period;
Sites / Locations
- the Third Affiliated Hospital of Sun Yat-Sen UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
percutaneous disc decompression with coblation nucleoplasty
Manual Therapy
PDCN will be performed in patients who are allocated to this group by using the COBLATION Perc-DC SpineWand surgical device (ArthroCare System 2000, ArthroCare corporation, Heredia, Costa Rica, USA)
Participants who are allocated to this group will undergo manual therapy treatments containing two kinds: sustained natural apophyseal glides (SNAGs) plus passive joint mobilisations (PJMs)